Literature DB >> 34043018

Transient Increase in Circulating Basophils and Eosinophils in Dupilumab-associated Conjunctivitis in Patients with Atopic Dermatitis.

Michie Katsuta1, Yozo Ishiuji, Hiroyuki Matsuzaki, Ken-Ichi Yasuda, Budiman Kharma, Yoshimasa Nobeyama, Takaaki Hayashi, Yoshiki Tokura, Akihiko Asahina.   

Abstract

Entities:  

Keywords:  basophils; dry eye; dupilumab associated conjunctivitis; eosinophils; atopic dermatitis

Mesh：

Substances：

Year:  2021        PMID： 34043018      PMCID： PMC9380271          DOI： 10.2340/00015555-3842

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   3.875


× No keyword cloud information.
  13 in total

1.  Incidence and risk factors for dupilumab associated ocular adverse events: a real-life prospective study.

Authors:  A T Touhouche; M Cassagne; E Bérard; F Giordano-Labadie; A Didier; P Fournié; C Paul; M Tauber
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-07-27       Impact factor: 6.166

2.  Dupilumab-induced ocular surface disease (DIOSD) in patients with atopic dermatitis: clinical presentation, risk factors for development and outcomes of treatment with tacrolimus ointment.

Authors:  Yoav Nahum; Michael Mimouni; Eitan Livny; Irit Bahar; Emmilia Hodak; Yael Anne Leshem
Journal:  Br J Ophthalmol       Date:  2019-09-25       Impact factor: 4.638

3.  Recurrence of conjunctival goblet cells after discontinuation of dupilumab in a patient with dupilumab-related conjunctivitis.

Authors:  A N Voorberg; W F A den Dunnen; R H J Wijdh; M S de Bruin-Weller; M L A Schuttelaar
Journal:  J Eur Acad Dermatol Venereol       Date:  2019-09-12       Impact factor: 6.166

4.  IL-33-Induced Atopic Dermatitis-Like Inflammation in Mice Is Mediated by Group 2 Innate Lymphoid Cells in Concert with Basophils.

Authors:  Yasutomo Imai; Koubun Yasuda; Makoto Nagai; Minori Kusakabe; Masato Kubo; Kenji Nakanishi; Kiyofumi Yamanishi
Journal:  J Invest Dermatol       Date:  2019-05-21       Impact factor: 8.551

5.  Mucous gland system of the conjunctiva. A quantitative normal anatomical study.

Authors:  S V Kessing
Journal:  Acta Ophthalmol (Copenh)       Date:  1968

6.  Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohort.

Authors:  Sarah Faiz; Jonathan Giovannelli; Céline Podevin; Marie Jachiet; Jean-David Bouaziz; Ziad Reguiai; Audrey Nosbaum; Audrey Lasek; Marie-Christine Ferrier le Bouedec; Aurélie Du Thanh; Nadia Raison-Peyron; Florence Tetart; Anne-Bénédicte Duval-Modeste; Laurent Misery; François Aubin; Anne Dompmartin; Cécile Morice; Catherine Droitcourt; Angèle Soria; Jean-Philippe Arnault; Juliette Delaunay; Emmanuel Mahé; Marie-Aleth Richard; Amélie Schoeffler; Jean-Philippe Lacour; Edouard Begon; Amélie Walter-Lepage; Anne-Sophie Dillies; Sandrine Rappelle-Duruy; Stéphane Barete; Nathalia Bellon; Nathalie Bénéton; Aude Valois; Sébastien Barbarot; Julien Sénéchal; Delphine Staumont-Sallé
Journal:  J Am Acad Dermatol       Date:  2019-02-27       Impact factor: 11.527

7.  Impression cytology in atopic dermatitis.

Authors:  M Dogru; C Katakami; N Nakagawa; K Tetsumoto; M Yamamoto
Journal:  Ophthalmology       Date:  1998-08       Impact factor: 12.079

Review 8.  Atopic keratoconjunctivitis: A review.

Authors:  Joseph J Chen; Danielle S Applebaum; Grace S Sun; Stephen C Pflugfelder
Journal:  J Am Acad Dermatol       Date:  2013-12-15       Impact factor: 11.527

9.  Laboratory safety of dupilumab in moderate-to-severe atopic dermatitis: results from three phase III trials (LIBERTY AD SOLO 1, LIBERTY AD SOLO 2, LIBERTY AD CHRONOS).

Authors:  A Wollenberg; L A Beck; A Blauvelt; E L Simpson; Z Chen; Q Chen; B Shumel; F A Khokhar; T Hultsch; E Rizova; A B Rossi; N M H Graham; G Pirozzi; Y Lu; M Ardeleanu
Journal:  Br J Dermatol       Date:  2019-12-01       Impact factor: 9.302

10.  Conjunctivitis in dupilumab clinical trials.

Authors:  B Akinlade; E Guttman-Yassky; M de Bruin-Weller; E L Simpson; A Blauvelt; M J Cork; E Prens; P Asbell; E Akpek; J Corren; C Bachert; I Hirano; J Weyne; A Korotzer; Z Chen; T Hultsch; X Zhu; J D Davis; L Mannent; J D Hamilton; A Teper; H Staudinger; E Rizova; G Pirozzi; N M H Graham; B Shumel; M Ardeleanu; A Wollenberg
Journal:  Br J Dermatol       Date:  2019-05-07       Impact factor: 9.302
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.